No Data
No Data
BeiGene Says Israeli Ministry Of Health Approved TEVIMBRA (Tislelizumab) As Monotherapy For Treatment Of Adult Patients With Unresectable Or Metastatic OESCC After Prior Systemic Chemotherapy
Express News | Beigene Receives Israeli Ministry of Health Approval for Tevimbra® for the Treatment of Oesophageal Squamous Cell Carcinoma (Oscc) After Prior Chemotherapy
BeiGene Receives Israeli Ministry of Health Approval for TEVIMBRA for the Treatment of Oesophageal Squamous Cell Carcinoma (OSCC) After Prior Chemotherapy
Hong Kong stock concept tracking | National Medical Products Administration accelerates the approval of clinical pharmaceuticals, institutions bullish on the high-speed development and profit period of innovative drugs (with concept stocks)
National Medical Products Administration: Accelerate the evaluation and approval of clinically urgent products and include eligible products in the priority evaluation and approval process.
BeiGene Singapore Raises Awareness for World Lymphoma Awareness Day 2024: It's Time for Honest Talk
Overnight news: European and American stock indexes closed up, gold hit a new high, the European Central Bank announced a rate cut, OpenAI's large-scale reasoning model made its debut, Samsung Electronics plans large-scale layoffs globally.
For more global financial news, please go to the 24/7 real-time financial news market closing: US stocks closed higher, led by technology stocks. The Nasdaq and S&P 500 indexes have risen for the fourth consecutive day. Top 20 US stock turnover on September 12: Wells Fargo & Co. restricted from conducting new business. China concept stocks had mixed performance on Thursday, with pdd holdings up 2.2% and Beigene down 7.1%. Crude oil closed up 2.5% on Thursday as hurricane disruptions supported oil prices. Spot gold hit a new record high, while major European stock indices rose collectively. The Euro Stoxx 50 index rose 1.04%. Macro Harris urged Trump to continue the presidential debate. Trump said he would not debate with Harris anymore.
No Data
No Data